#HVO hVIVO PLC – Trading Update and Acquisition January 29, 2025 – Posted in: hVIVO (HVO)

hVIVO plc (AIM: HVO), a fast-growing specialist early-stage drug development contract research organisation (CRO) and world leader in testing infectious and respiratory disease products using human challenge clinical trials, provides an unaudited trading update for the year ended 31 December 2024.   Highlights ·    Revenue up 11.9% to £62.7 million (2023: £56.0 million) ·    EBITDA margin of c.26% (2023: 23.3%) ·    Cash of £44.2 million as at 31 December 2024 (31 December 2023: £37.0 million)…

Continue reading

#VELA investee co. #MTI Wireless Edge LTD – Interim Results August 15, 2023 – Posted in: Blog, Vela Technologies Plc (VELA)

MTI Wireless Edge Ltd (AIM: MWE), the technology group focused on comprehensive communication and radio frequency solutions across multiple sectors, is pleased to today announce its financial results for the six month period ended 30 June 2023.   ‘Significant improvement in Operating Cashflow – a steady performance and on track for the year’ Financial highlights ·    Revenues broadly level at US$22.4m (H1 2022: US$22.7m), held back by adverse currency translation.  On a constant currency basis…

Continue reading